In this regard, it is interesting to note that many preclinical studies have reported the therapeutic efficacies of Sig-1R ligands in ameliorating stroke-or β-amyloid-induced neurodegeneration [8], [43] and in promoting neuroplasticity related to drug abuse [8], . This evidence concerns the gene SIGMAR1 and stroke disorder.